Citadel Advisors’s Global Cord Blood Corporation CO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,800
| Closed | -$32.3K | – | 15794 |
|
|
2023
Q1 | $32.3K | Hold |
10,800
| – | – | ﹤0.01% | 12655 |
|
|
2022
Q4 | $32.3K | Hold |
10,800
| – | – | ﹤0.01% | 12649 |
|
|
2022
Q3 | $32K | Sell |
10,800
-23,174
| -68% | -$56.9K | ﹤0.01% | 11886 |
|
|
2022
Q2 | $101K | Buy |
33,974
+3,471
| +11% | +$10.8K | ﹤0.01% | 11409 |
|
|
2022
Q1 | $117K | Buy |
30,503
+799
| +3% | +$3.32K | ﹤0.01% | 12119 |
|
|
2021
Q4 | $124K | Buy |
29,704
+2,914
| +11% | +$12.4K | ﹤0.01% | 12492 |
|
|
2021
Q3 | $125K | Sell |
26,790
-9,804
| -27% | -$48.1K | ﹤0.01% | 12604 |
|
|
2021
Q2 | $195K | Buy |
36,594
+26,567
| +265% | +$139K | ﹤0.01% | 12191 |
|
|
2021
Q1 | $45K | Sell |
10,027
-2,275
| -18% | -$9.87K | ﹤0.01% | 12945 |
|
|
2020
Q4 | $46K | Sell |
12,302
-26
| -0.2% | -$100 | ﹤0.01% | 10596 |
|
|
2020
Q3 | $44K | Sell |
12,328
-13,639
| -53% | -$47.3K | ﹤0.01% | 9652 |
|
|
2020
Q2 | $80K | Buy |
25,967
+4,852
| +23% | +$14.1K | ﹤0.01% | 9114 |
|
|
2020
Q1 | $67K | Buy |
21,115
+711
| +3% | +$3.11K | ﹤0.01% | 8888 |
|
|
2019
Q4 | $102K | Sell |
20,404
-29,735
| -59% | -$142K | ﹤0.01% | 8542 |
|
|
2019
Q3 | $243K | Buy |
50,139
+23,603
| +89% | +$124K | ﹤0.01% | 7885 |
|
|
2019
Q2 | $153K | Sell |
26,536
-18,327
| -41% | -$121K | ﹤0.01% | 8347 |
|
|
2019
Q1 | $315K | Sell |
44,863
-58,524
| -57% | -$387K | ﹤0.01% | 7544 |
|
|
2018
Q4 | $667K | Buy |
+103,387
| New | +$661K | ﹤0.01% | 5952 |
|
|
2018
Q2 | – | Sell |
-88,754
| Closed | -$905K | – | 9683 |
|
|
2018
Q1 | $905K | Buy |
88,754
+17,771
| +25% | +$182K | ﹤0.01% | 4975 |
|
|
2017
Q4 | $706K | Buy |
+70,983
| New | +$776K | ﹤0.01% | 5157 |
|
|
2017
Q3 | – | Sell |
-21,973
| Closed | -$208K | – | 8425 |
|
|
2017
Q2 | $208K | Buy |
+21,973
| New | +$175K | ﹤0.01% | 6513 |
|
|
2016
Q1 | – | Sell |
-21,168
| Closed | -$135K | – | 8744 |
|
|
2015
Q4 | $135K | Buy |
+21,168
| New | +$134K | ﹤0.01% | 6343 |
|
Other funds holding CO
UB
OA
SPIA
Citadel Advisors's CO Position: Q2 2023 in Review
Citadel Advisors sold out of Global Cord Blood Corporation (CO) in Q2 2023, closing a stake of 10,800 shares — an estimated $32.3K sold.
Citadel Advisors first reported a position in CO in Q4 2015 and held it in 22 quarters. The position peaked at $905K in Q1 2018. 6 funds tracked by Wall St. Rank hold CO as of Q2 2023.
- Citadel Advisors reported no remaining Global Cord Blood Corporation position as of Q2 2023 after selling out during the quarter.
- Citadel Advisors sold 10,800 Global Cord Blood Corporation shares in Q2 2023, an estimated $32.3K.
- Citadel Advisors first reported a position in Global Cord Blood Corporation in Q4 2015 and held it in 22 quarters.
- Citadel Advisors's Global Cord Blood Corporation position peaked at $905K in Q1 2018.
- 6 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q2 2023.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.